comparemela.com

Latest Breaking News On - Annexon inc - Page 8 : comparemela.com

Annexon, Inc (NASDAQ:ANNX) Receives Average Rating of Buy from Brokerages

Shares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the company, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have covered the stock in the […]

Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference

BRISBANE, Calif., April 03, 2024 Annexon, Inc. , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical.

Research Analysts Price Target Changes for April 1st (AAPL, ABCB, ABNB, AFMD, ALL, ALT, AMX, AMZN, ANAB, ANNX)

Research Analysts’ price target changes for Monday, April 1st: Apple (NASDAQ:AAPL) had its target price lowered by Loop Capital from $185.00 to $170.00. Loop Capital currently has a hold rating on the stock. Ameris Bancorp (NASDAQ:ABCB) had its target price lowered by Truist Financial Co. from $60.00 to $54.00. The firm currently has a buy […]

Annexon s (ANNX) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed their buy rating on shares of Annexon (NASDAQ:ANNX – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $16.00 target price on the stock. Other equities analysts have also recently issued reports about the stock. HC Wainwright reaffirmed a buy rating and […]

HC Wainwright Comments on Annexon, Inc s Q1 2024 Earnings (NASDAQ:ANNX)

HC Wainwright Comments on Annexon, Inc s Q1 2024 Earnings (NASDAQ:ANNX)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.